GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001065.PFD) » Definitions » Cyclically Adjusted PS Ratio

JW Pharmaceutical (XKRX:001065.PFD) Cyclically Adjusted PS Ratio : (As of May. 21, 2025)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


JW Pharmaceutical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for JW Pharmaceutical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Cyclically Adjusted PS Ratio Chart

JW Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 0.94 0.75 1.43 0.92

JW Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 1.19 1.06 0.92 0.78

Competitive Comparison of JW Pharmaceutical's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Pharmaceutical's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Cyclically Adjusted PS Ratio falls into.


;
;

JW Pharmaceutical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

JW Pharmaceutical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, JW Pharmaceutical's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=16662.424/122.5900*122.5900
=16,662.424

Current CPI (Mar. 2025) = 122.5900.

JW Pharmaceutical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 10,055.440 100.051 12,320.717
201509 9,942.023 100.111 12,174.437
201512 9,523.162 100.220 11,648.770
201603 10,725.547 100.561 13,075.110
201606 10,481.167 100.791 12,748.064
201609 10,695.221 101.461 12,922.449
201612 10,147.639 101.561 12,248.751
201703 11,090.021 102.851 13,218.452
201706 10,910.508 102.611 13,034.814
201709 11,987.472 103.491 14,199.798
201712 11,250.695 102.991 13,391.708
201803 11,752.519 104.101 13,839.868
201806 11,934.404 104.130 14,050.076
201809 13,179.618 105.651 15,292.775
201812 11,454.226 104.351 13,456.293
201903 11,718.899 104.491 13,748.755
201906 12,065.840 104.881 14,103.152
201909 11,965.010 105.200 13,942.836
201912 10,246.054 105.121 11,948.708
202003 11,605.924 105.354 13,504.637
202006 12,274.803 105.112 14,315.882
202009 12,336.245 106.198 14,240.437
202012 13,017.149 105.765 15,087.848
202103 12,781.707 107.357 14,595.290
202106 13,135.711 107.579 14,968.654
202109 13,402.148 108.759 15,106.486
202112 15,244.160 109.676 17,039.049
202203 14,063.247 111.848 15,413.896
202206 14,842.517 114.072 15,950.798
202209 15,278.104 114.715 16,326.879
202212 17,375.104 115.179 18,493.044
202303 15,596.231 116.507 16,410.477
202306 16,724.168 117.182 17,495.981
202309 16,569.470 118.964 17,074.562
202312 18,441.849 118.837 19,024.246
202403 16,244.807 120.123 16,578.404
202406 15,496.628 120.007 15,830.134
202409 16,070.437 120.861 16,300.309
202412 16,897.650 121.135 17,100.586
202503 16,662.424 122.590 16,662.424

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


JW Pharmaceutical  (XKRX:001065.PFD) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


JW Pharmaceutical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines